Overview
Waardenburg syndrome type 3 (WS3), also known as Klein-Waardenburg syndrome, is a rare genetic disorder characterized by the combination of pigmentary abnormalities, sensorineural hearing loss, and musculoskeletal anomalies of the upper limbs. It is considered the most severe form within the Waardenburg syndrome spectrum. The condition results from mutations in the PAX3 gene located on chromosome 2q36, which plays a critical role in the development of neural crest-derived cells, including melanocytes and certain musculoskeletal structures. Key clinical features include dystopia canthorum (lateral displacement of the inner corners of the eyes), a broad nasal root, synophrys (confluent eyebrows), heterochromia iridis (different colored eyes) or brilliant blue eyes, white forelock or premature graying of the hair, and patchy skin depigmentation. The distinguishing feature of WS3 compared to other Waardenburg subtypes is the presence of upper limb abnormalities, which can range from hypoplasia of the limb muscles to contractures of the fingers (camptodactyly), syndactyly (fusion of fingers), or more severe limb reduction defects. Sensorineural hearing loss, which may be unilateral or bilateral and ranges from mild to profound, is present in a significant proportion of affected individuals. There is currently no cure for Waardenburg syndrome type 3. Management is supportive and multidisciplinary. Early identification and intervention for hearing loss, including hearing aids or cochlear implants, is essential for speech and language development. Orthopedic evaluation and management may be needed for upper limb anomalies. Dermatologic counseling regarding sun protection for depigmented skin areas and ophthalmologic monitoring are also recommended. Genetic counseling is important for affected families to understand recurrence risks.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Waardenburg syndrome type 3.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Waardenburg syndrome type 3 at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Waardenburg syndrome type 3.
Community
No community posts yet. Be the first to share your experience with Waardenburg syndrome type 3.
Start the conversation →Latest news about Waardenburg syndrome type 3
No recent news articles for Waardenburg syndrome type 3.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Waardenburg syndrome type 3
What is Waardenburg syndrome type 3?
Waardenburg syndrome type 3 (WS3), also known as Klein-Waardenburg syndrome, is a rare genetic disorder characterized by the combination of pigmentary abnormalities, sensorineural hearing loss, and musculoskeletal anomalies of the upper limbs. It is considered the most severe form within the Waardenburg syndrome spectrum. The condition results from mutations in the PAX3 gene located on chromosome 2q36, which plays a critical role in the development of neural crest-derived cells, including melanocytes and certain musculoskeletal structures. Key clinical features include dystopia canthorum (lat
How is Waardenburg syndrome type 3 inherited?
Waardenburg syndrome type 3 follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Waardenburg syndrome type 3 typically begin?
Typical onset of Waardenburg syndrome type 3 is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Waardenburg syndrome type 3?
3 specialists and care centers treating Waardenburg syndrome type 3 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.